Financials

  • Market Capitalization 270.57 M
  • Employee 63
  • Founded 2019
  • CEO N/A
  • Website www.neumoratx.com
  • Headquarter Delaware, United States
  • FIGI BBG012W9C4X1
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.23
Relación precio/flujo de caja
-592.04

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3407
ACIU
AC Immune SA - Common Stock
2.67 USD-1.48%-7.93%+16.59%+29.61%271.65 M USD
3411
TRDA
Entrada Therapeutics, Inc. - Common Stock
6.98 USD-3.99%-7.06%+20.76%+0.14%271.78 M USD
3419
PYXS
Pyxis Oncology, Inc. - Common Stock
3.24 USD-2.41%+5.19%+11.72%+141.79%270.24 M USD
3422
SION
Sionna Therapeutics, Inc. - Common Stock
5.97 USD-1.49%+10.97%-87.25%-84.82%269.92 M USD

Noticias